Research Cell Bank definition

Research Cell Bank is a [***].
Research Cell Bank or “RCB” shall mean a small cell bank produced under research conditions used for the production of Research DNA only. This material is provided “as-is”.
Research Cell Bank means a non GMP cell bank of the Manufacturing Strain for a Collaboration Product meeting the specifications therefor as set forth in the Development Plan for such Collaboration Product.

Examples of Research Cell Bank in a sentence

  • Invoicing of License fees will commence from the date WuXi Biologics completes Research Cell Bank generation from the Licensed Cell Line.

  • As a follow-on to the successful production, testing, and selection of a CS protein expressing cell line under the original subcontract and Mod 2 which composed of : (i)-Evaluation of CSP expression (Stage 1), (ii)-Fermentation assessment of CSP (Stage 2), (iii)-CSP purification (Stage 2A/Mod 2) and (iv)-Preparation and characterization of Pseudumonas-CSP Research Cell Bank (RCB) (Stage 3), SAIC requires Pfenex to provide [*] using the process established in Stage 2A.

  • Research Cell Bank, plasmid amplification (pDNA) at 20-30 L scale, Drug substance (mRNA) at 10-20L, bulk drug product (encapsulated mRNA) processes.

  • The selected strain will be used for establishment of a Research Cell Bank (RCB) and in parallel for manufacturing of a Master Cell Bank (MCB) and a Working Cell Bank (WCB).

  • Manufacturing of Streptococcus pneumoniae Vaccine Candidate May 21, 2020 Process Establishment: We will generate a Research Cell Bank based on the cultures provided by Blue Water (Task 4).

  • These services pertain to the development and preparation of stable CHO cell lines capable of efficiently overproducing a specific antibody fragment (scFvFc), as well as the establishment of a Research Cell Bank (RCB) and a Master Cell Bank (MCB) under cGMP-compliant conditions, optimized for fed-batch culture systems.

  • WuXi Biologics shall submit an invoice to Licensee for the License Fee within [***] days after the date that WuXi Biologics completes Research Cell Bank generation from the Licensed Cell Line.


More Definitions of Research Cell Bank

Research Cell Bank or “RCB” shall mean an E. coli cell bank or CHO cell bank expressing TriKE Product produced under research conditions used for the production of the R&D Batch. The RCB should be derived from a single E. coli cell clone or CHO cell clone expressing the TriKE product.
Research Cell Bank means a cryopreserved bank of selected monoclonal cell line, not fully characterized but suitable for use as a seed stock for the development of a fully characterized Master Cell ABZ [ ] 4 Confidential ​
Research Cell Bank means, to the extent related to the Compound aflibercept, a vialed collection of serially sub-cultivated cells prepared under defined culture conditions, preceding the Master Cell Bank and used to establish seed cultures of a Biosimilar Cell Line for development of such Compound. For the avoidance of doubt, the Research Cell Bank include any and all protoclones and pools related to such Compound.
Research Cell Bank is a known quantity of cryopreserved or frozen cells of the Licensed Cell Line that was derived during cell line development activities at WuXi Biologics. 1.17 “Technology Transfer Package” means the information and data to be provided to Licensee describing the Process and Licensed Know-How, Materials and Media and Feeds for manufacture of Client Product using the Licensed Cell Line and/or the Process. 1.18 “Third Party” means any person other than the Parties to this Agreement. 1.19 “Third Party Manufacturer” means (i) a Third Party whose primary business is contract manufacturing, or (ii) a Third Party who has a contractual arrangement with Licensee or with a sublicensee of Licensee that includes manufacturing of Client Product and/or Drug Product and/or Drug Substance by such Third Party for Licensee or such sublicensee.
Research Cell Bank or “RCB” shall mean an aliquot of a single pool of genetically engineered E-Coli cells that have been prepared from the selected cell clone under defined conditions, dispensed into multiple containers and able to produce recombinant human insulin, used in the manufacturing of the finished dose formulation for biosimilar [***], meeting the Specifications, including the Reference Product specifications, conditions for the Manufacture, use or sale of the Products.